HomePVCT • OTCMKTS
add
Provectus Biopharmaceuticals Inc
Previous close
$0.18
Day range
$0.17 - $0.18
Year range
$0.056 - $0.22
Market cap
73.58M USD
Avg Volume
213.50K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 121.11K | -26.53% |
Operating expense | -68.80K | -589.18% |
Net income | -663.41K | 9.45% |
Net profit margin | -547.78 | -23.24% |
Earnings per share | — | — |
EBITDA | -215.37K | -34.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 76.58K | 254.44% |
Total assets | 1.45M | -28.88% |
Total liabilities | 9.04M | 9.39% |
Total equity | -7.59M | — |
Shares outstanding | 419.52M | — |
Price to book | -8.83 | — |
Return on assets | -34.66% | — |
Return on capital | 12.18% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -663.41K | 9.45% |
Cash from operations | -561.21K | 25.65% |
Cash from investing | — | — |
Cash from financing | 201.55K | -57.49% |
Net change in cash | -383.41K | -37.11% |
Free cash flow | -271.42K | 3.91% |
About
Founded
2002
Headquarters
Website
Employees
4